US 10076535
Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
granted A61KA61K31/4745A61K31/7036
Quick answer
US patent 10076535 (Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/4745, A61K31/7036, A61K31/711, A61K31/713